Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

<p>All Supplementary Tables</p>

Saved in:

書目詳細資料
主要作者:	Evangeline R. Jackson (15558808) (author)
其他作者:	Ryan J. Duchatel (15558811) (author), Dilana E. Staudt (15558814) (author), Mika L. Persson (15558817) (author), Abdul Mannan (15558820) (author), Sridevi Yadavilli (15558823) (author), Sarah Parackal (15558826) (author), Shaye Game (15558829) (author), Wai Chin Chong (15558832) (author), W. Samantha N. Jayasekara (15558835) (author), Marion Le Grand (15558838) (author), Padraic S. Kearney (15558841) (author), Alicia M. Douglas (15558844) (author), Izac J. Findlay (15558847) (author), Zacary P. Germon (15558850) (author), Holly P. McEwen (15558853) (author), Tyrone S. Beitaki (15558856) (author), Adjanie Patabendige (15558859) (author), David A. Skerrett-Byrne (15558862) (author), Brett Nixon (9587818) (author), Nathan D. Smith (15558865) (author), Bryan Day (15558868) (author), Neevika Manoharan (15558871) (author), Sumanth Nagabushan (15558874) (author), Jordan R. Hansford (15022992) (author), Dinisha Govender (15558877) (author), Geoff B. McCowage (15558880) (author), Ron Firestein (15558883) (author), Meegan Howlett (15558886) (author), Raelene Endersby (15558889) (author), Nicholas G. Gottardo (15558892) (author), Frank Alvaro (15558895) (author), Sebastian M. Waszak (15042965) (author), Martin R. Larsen (15558898) (author), Yolanda Colino-Sanguino (15558901) (author), Fatima Valdes-Mora (15558904) (author), Andria Rakotomalala (15558907) (author), Samuel Meignan (15558910) (author), Eddy Pasquier (15558913) (author), Nicolas André (15119506) (author), Esther Hulleman (15558916) (author), David D. Eisenstat (15558919) (author), Nicholas A. Vitanza (15122158) (author), Javad Nazarian (15558922) (author), Carl Koschmann (15558925) (author), Sabine Mueller (15042968) (author), Jason E. Cain (15558928) (author), Matthew D. Dun (15122218) (author)
出版:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling CNS Cancers Drug Mechanisms Cellular responses to anticancer drugs Metabolism Mitochondrial function Pediatric Cancers Proteomics Rare Cancers Systems Biology
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
由: Gwo Yaw Ho (14961416)
出版: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
由: Alyssa C. Flint (16676029)
出版: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
由: Alyssa C. Flint (16676029)
出版: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
由: Nicole A. Traphagen (16677391)
出版: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
由: Nicole A. Traphagen (16677391)
出版: (2025)

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S5 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S6 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S7 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S8 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
由: Fang Wei (15057172)
出版: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
由: Jesse C. Patterson (14962862)
出版: (2025)

Supplementary Table S1 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Table S2 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Table S3 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Table S4 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Table S5 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Table S6 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Table S7 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
由: Amr El Zawily (14851115)
出版: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
由: Lixuan Wei (14962431)
出版: (2025)

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
由: Juliana Navarro-Yepes (17079059)
出版: (2025)

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
由: Michael D. Nyquist (16918265)
出版: (2025)

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
由: Michael D. Nyquist (16918265)
出版: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
由: Jiwei Bai (15051797)
出版: (2025)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
由: Zijing Wang (17141626)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_jpuep8vlsq42a8pq6em5rf9gp8